NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years and Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS
Listen to Dr. Brown discuss with Dr. Saseen the Scientific Statement from the NLA and the AGS on managing hypercholesterolemia in adults aged 57 and…
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the 2019 NLA Scientific Statement On…
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
Statin intolerance is defined as one or more adverse effects associated with statin therapy which resolves or improves with dose reduction or discontinuation and can…
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
This scientific statement reviews the pre-analytical, analytical, post-analytical, and clinical aspects of lipoprotein measurements.
S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement
Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on…
The National Lipid Association scientific statement on coronary artery calcium (CAC) scoring to guide preventive strategies for ASCVD risk reduction
An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for…
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
There is clinical utility of genetic testing for familial hypercholesterolemia, familial chylomicronemia syndrome, sitosterolemia, lysosomal acid lipase deficiency, and a few other rare disorders, and…
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
The 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol reaffirmed that lifestyle changes and statin treatment are therapeutic cornerstones…
- 1
- 2